Search

Search Constraints

You searched for: Date 2022 Author/Creator Subbiah, Vivek

Search Results

1. 2022-RA-262-ESGO Predictors of oncologic outcome in recurrent cervical cancer patients receiving phase 1 cancer therapy. (20th October 2022)

4. Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial. Issue 1 (January 2022)

6. Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study. (September 2022)

10. Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial. Issue 2 (19th September 2022)